TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
21.62%
1 Year Est. Return
+21.62%
AUM
$1.81B
AUM Growth
+$296M
(+20%)
Holding
208
Top Buys
| 1 | +$50.6M | |
| 2 | +$45.2M | |
| 3 | +$33.1M | |
| 4 |
Spyre Therapeutics
SYRE
|
+$33.1M |
| 5 |
SLRN
ACELYRIN
SLRN
|
+$24.3M |
Top Sells
| 1 | +$10.6M | |
| 2 | +$7.23M | |
| 3 | +$4.82M | |
| 4 |
ALMS
Alumis Inc
ALMS
|
+$4.72M |
| 5 |
Seer Inc
SEER
|
+$1.52M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Technology | 1.25% |
| 3 | Communication Services | 1.23% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$260B
| $18.4M | 1.02% |
250,000
+100,000
|
|
||
27
Liquidia Corp
LQDA
$1.97B
| $17.7M | 0.98% |
1,200,000
+100,000
|
|
||
28
Neurocrine Biosciences
NBIX
$14.1B
| $16.6M | 0.92% |
150,000
|
|
||
|
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.8B
| $16.4M | 0.91% |
2,097,500
+600,000
|
|
||
|
ITOS
30
DELISTED
iTeos Therapeutics
ITOS
| $16.1M | 0.89% |
2,689,200
+2,467,484
|
|
||
31
Meta Platforms (Facebook)
META
$1.84T
| $15.9M | 0.88% |
27,575
+975
|
|
||
32
GSK
GSK
$88.9B
| $15.5M | 0.86% |
400,000
|
|
||
33
NVIDIA
NVDA
$4.39T
| $15.5M | 0.85% |
142,569
|
|
||
34
Sanofi
SNY
$123B
| $15M | 0.83% |
270,000
|
|
||
35
Atea Pharmaceuticals
AVIR
$259M
| $14.4M | 0.79% |
4,800,000
+11,088
|
|
||
36
Altimmune
ALT
$342M
| $13.8M | 0.76% |
2,750,000
|
|
||
37
Zymeworks
ZYME
$1.34B
| $13.1M | 0.72% |
1,100,000
|
|
||
38
Nkarta
NKTX
$160M
| $13M | 0.72% |
7,055,576
+4,761,857
|
|
||
|
CRGX
39
DELISTED
CARGO Therapeutics
CRGX
| $12.5M | 0.69% |
3,059,630
+2,419,630
|
|
||
|
CYBN
40
Cybin
CYBN
$149M
| $11.6M | 0.64% |
1,830,097
+500,000
|
|
||
41
Vaxcyte
PCVX
$5.52B
| $11.3M | 0.63% |
300,000
|
|
||
42
Keros Therapeutics
KROS
$466M
| $11.2M | 0.62% |
+1,100,000
|
|
||
43
Teladoc Health
TDOC
$1.52B
| $11.1M | 0.62% |
1,400,000
|
|
||
44
Journey Medical
DERM
$197M
| $10.9M | 0.61% |
1,854,596
+129,027
|
|
||
45
Vanda Pharmaceuticals
VNDA
$310M
| $10.8M | 0.6% |
2,353,307
|
|
||
|
ONC
46
BeOne Medicines Ltd
ONC
$34.5B
| $10.1M | 0.56% |
37,000
|
|
||
47
Arvinas
ARVN
$688M
| $9.78M | 0.54% |
+1,393,800
|
|
||
48
Harmony Biosciences
HRMY
$1.51B
| $9.33M | 0.52% |
281,200
|
|
||
49
Alibaba
BABA
$386B
| $9.26M | 0.51% |
+70,000
|
|
||
50
CRISPR Therapeutics
CRSP
$6.07B
| $9.07M | 0.5% |
266,500
|
|